BIOR - BIORA THERAPEUTICS, INC.
0.5461
-0.214 -39.169%
Share volume: 0
Last Updated: Tue 10 Dec 2024 09:29:11 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.19%
PREVIOUS CLOSE
CHG
CHG%
$0.76
-0.21
-28.14%
View ratios
Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2023-05-15 | 2023-08-14 | 2023-11-13 | 2024-04-01 | 2024-05-15 | |
Assets | ||||||
Total Assets | 53.243 M | 49.673 M | 34.703 M | 31.215 M | 22.990 M | |
Current Assets | 37.168 M | 33.885 M | 19.247 M | 19.071 M | 14.071 M | |
Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Other Current Assets | 3.368 M | 4.105 M | 3.351 M | 3.030 M | 2.429 M | |
Short Term Investments | 3.368 M | 4.105 M | 3.351 M | 3.030 M | 2.429 M | |
Total Receivables | 828.000 K | 819.000 K | 818.000 K | 830.000 K | 822.000 K | |
Current Cash | 30.463 M | 26.452 M | 12.569 M | 15.211 M | 10.820 M | |
Total Non-current Assets | 16.075 M | 15.788 M | 15.456 M | 12.144 M | 8.919 M | |
Property Plant Equipment | 1.498 M | 1.351 M | 1.236 M | 1.156 M | 1.136 M | |
Other Assets | 8.505 M | 8.365 M | 8.148 M | 4.916 M | 1.711 M | |
Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Goodwill | 6.072 M | 6.072 M | 6.072 M | 6.072 M | 6.072 M | |
Liabilities and shareholders’ equity | ||||||
Total Liabilities and shareholders’ equity | 53.243 M | 49.673 M | 34.703 M | 31.215 M | 22.990 M | |
Total liabilities | 158.241 M | 170.554 M | 153.489 M | 132.636 M | 123.175 M | |
Total current liabilities | 25.083 M | 37.668 M | 69.544 M | 62.972 M | 51.104 M | |
Accounts Payable | 3.422 M | 5.042 M | 3.905 M | 2.843 M | 4.936 M | |
Other liabilities | 4.973 M | 4.318 M | 3.567 M | 25.928 M | 28.793 M | |
Current long term debt | 0.000 | 0.000 | 0.000 | 1.976 M | 1.976 M | |
Long term debt | 128.185 M | 128.568 M | 80.378 M | 43.736 M | 43.278 M | |
Other liabilities | 4.973 M | 4.318 M | 3.567 M | 25.928 M | 28.793 M | |
Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Total Shareholder equity | -104.998 M | -120.881 M | -118.786 M | -101.421 M | -100.185 M | |
Common stock | 10.971 M | 12.143 M | 15.025 M | 24.955 M | 29.297 M | |
Retained earnings | -844.284 M | -862.091 M | -935.545 M | -950.958 M | -955.147 M |